Literature DB >> 18712462

Chemotherapy-resistant intravascular lymphoma accompanied by ADAMTS13 inhibitor successfully treated with rituximab.

Masatoshi Kanno1, Shinobu Nakamura2, Makoto Kawahara3, Satoshi Ueno3, Hirokazu Nakamine4, Masanori Matsumoto5, Yoshihiro Fujimura5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18712462     DOI： 10.1007/s12185-008-0143-y

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  10 in total

1.  An Asian variant of intravascular large B-cell lymphoma: clinical, pathological and cytogenetic approaches to diffuse large B-cell lymphoma associated with haemophagocytic syndrome.

Authors:  T Murase; S Nakamura; K Kawauchi; H Matsuzaki; C Sakai; T Inaba; K Nasu; K Tashiro; T Suchi; H Saito
Journal:  Br J Haematol       Date:  2000-12       Impact factor: 6.998

2.  Successful treatment of relapse of an intravascular B-cell lymphoma with rituximab-CHOP polychemotherapy.

Authors:  István Takács; N Eros; I Bene; F Bozsó; L Tordai; Z Károlyi; G Radványi; A Matolcsy
Journal:  Ann Hematol       Date:  2004-06-16       Impact factor: 3.673

3.  Intravascular large B-cell lymphoma presenting with mass lesions in the central nervous system: a report of five cases.

Authors:  Hiroshi Imai; Kazuyoshi Kajimoto; Masashi Taniwaki; Ikuo Miura; Yoshihiro Hatta; Yoshio Hashizume; Masatoshi Watanabe; Taizo Shiraishi; Shigeo Nakamura
Journal:  Pathol Int       Date:  2004-04       Impact factor: 2.534

4.  Severe pulmonary complications after initial treatment with Rituximab for the Asian-variant of intravascular lymphoma.

Authors:  Shang-Ju Wu; Wen-Chien Chou; Bo-Sheng Ko; Hwei-Fang Tien
Journal:  Haematologica       Date:  2007-01       Impact factor: 9.941

5.  Intravascular lymphoma: a role for single-agent rituximab.

Authors:  Lyudmila Bazhenova; Philip Higginbottom; James Mason
Journal:  Leuk Lymphoma       Date:  2006-02

6.  Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5.

Authors:  Takuhei Murase; Motoko Yamaguchi; Ritsuro Suzuki; Masataka Okamoto; Yumiko Sato; Jun-ichi Tamaru; Masaru Kojima; Ikuo Miura; Naoyoshi Mori; Tadashi Yoshino; Shigeo Nakamura
Journal:  Blood       Date:  2006-09-19       Impact factor: 22.113

7.  Diffuse neurodeficits in intravascular lymphomatosis with ADAMTS13 inhibitor.

Authors:  M Kawahara; M Kanno; M Matsumoto; S Nakamura; Y Fujimura; S Ueno
Journal:  Neurology       Date:  2004-11-09       Impact factor: 9.910

8.  Intravascular large B-Cell lymphoma with bone marrow involvement and superior sagittal sinus thrombosis: report of a case successfully treated with a CHOP/rituximab combination regimen.

Authors:  Fabrice Jardin; Françoise Callonnec; Nathalie Contentin; Jean-Michel Picquenot; Isabelle Gueit; François Héron; Christian Bastard; Hervé Tilly
Journal:  Clin Lymphoma       Date:  2005-06

Review 9.  Angiotropic large cell lymphoma presenting as thrombotic microangiopathy (thrombotic thrombocytopenic purpura).

Authors:  H Sill; G Höfler; P Kaufmann; J Horina; E Spuller; R Kleinert; C Beham-Schmid
Journal:  Cancer       Date:  1995-03-01       Impact factor: 6.860

10.  Evaluation of organ involvement in intravascular large B-cell lymphoma by 18F-fluorodeoxyglucose positron emission tomography.

Authors:  Kazuyuki Shimada; Hiroshi Kosugi; Satoko Shimada; Hiroto Narimatsu; Yoshitsugu Koyama; Nobuaki Suzuki; Masaaki Yuge; Hironori Nishibori; Yosuke Iwata; Shigeo Nakamura; Tomoki Naoe; Tomohiro Kinoshita
Journal:  Int J Hematol       Date:  2008-05-22       Impact factor: 2.490
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.